MACK - Merrimack Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

with an average price target of $127.33. This is a potential upside of $112.6 (764.43%) from yesterday's end of day stock price of $14.73.

Merrimack Pharmaceuticals's activity chart (see below) currently has 4 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 498 days.

Most recent stock forecast was given by LING WANG from on 10-Nov-2016. First documented stock forecast 12-Aug-2015.

Best performing analysts who are covering MACK - Merrimack Pharmaceuticals:

Ling Wang

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

7 years 5 months 17 days ago

2/3 (66.67%)

$112.6 (301.07%)

498

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MACK (Merrimack Pharmaceuticals) average time for price targets to be met?

On average it took 498 days on average for the stock forecasts to be realized with a an average price target met ratio 66.67

Which analyst has the current highest performing score on MACK (Merrimack Pharmaceuticals) with a proven track record?

LING WANG

Which analyst has the most public recommendations on MACK (Merrimack Pharmaceuticals)?

Ling Wang has 6 price targets and 9 ratings on MACK

Which analyst is the currently most bullish on MACK (Merrimack Pharmaceuticals)?

Ling Wang with highest potential upside - $0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?